Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2010-03-05
2011-10-25
Saeed, Kamal (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S391000, C548S301400, C548S319500
Reexamination Certificate
active
08044082
ABSTRACT:
Novel N-phenylacetamide compounds of formula (I):and cosmetic and pharmaceutical compositions containing same are useful for treating disorders of the sebaceous gland, e.g., acne, or have cosmetic applications.
REFERENCES:
patent: 2007/0197617 (2007-08-01), Chen et al.
patent: 0 987 254 (2000-03-01), None
patent: 1 421 294 (2004-06-01), None
patent: 2007-176809 (2007-07-01), None
patent: WO 2005/082879 (2005-09-01), None
patent: WO 2007/061880 (2007-05-01), None
Vippagunta et al., Crystalline solids, 2001, Advanced Drug Delivery Reviews, 48, pp. 3 and 18.
Peterson et al., Expanding the scope of Crystal form evaluation in Pharmaceutical Science, 2006, J Pharm Pharmaceut Sci, 9(3), pp. 317-326.
Patrick M. O'Brien et al., “Inhibitors of Acyl-CoA:Cholesterol O-Acyltransferase. Synthesis and Pharmacological Activity of (±)-2-Dodecyl-α-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5-actamide and Structurally Related Tetrazole Amide Derivatives,”Journal of Medicinal Chemistry, Mar. 4, 1996, pp. 2354-2366, vol. 39, No. 12, American Chemical Society.
Andrew D. White et al., “Heterocyclic Amides: Inhibitors of Acyl-CoA:Cholesterol O-Acyl Transferase with Hypocholesterolemic Activity in Several Species and Antiatherosclerotic Activity in the Rabbit,”Journal of Medicinal Chemistry, Jun. 6, 1996, pp. 3908-3919, vol. 39, No. 20, American Chemical Society.
Patrick M. O'Brien et al., “Inhibitors of Acyl-CoA:Cholesterol O-Acyl Transferase (ACAT) as Hypocholesterolemic Agents. 8.1Incorporation of Amide of Amine Functionalities into a Series of Disubstituted Ureas and Carbamates. Effect on ACAT Inhibition in Vitro and Efficacy in Vivo,”Journal of Medicinal Chemistry, Dec. 20, 1993, pp. 1810-1822, vol. 37, No. 12, American Chemical Society.
Bharat Trivedi et al., Inhibitors of Acyl-CoA:Cholesterol Acyltransferase. 4. A Novel Series of Urea ACAT Inhibitors as Potential Hypocholesterolemic Agents,:Journal of Medicinal Chemistry, May 20, 1993, pp. 3300-3307, vol. 36, No. 22, American Chemical Society.
Corinne Augelli-Szafran et al., “Imidazolidinones and Pyrazolones As Novel ACAT Inhinitors: Chemistry and Biological Activity,”Bioorganic&Medicinal Chemistry Letters, 1994, pp. 1095-1100, vol. 4, No. 9, Elsevier, Great Britain.
R. Bellemin et al., “New Indole Derivatives as ACAT Inhibitors: Synthesis and Structure-Activity Relationships,”European Journal of Medicinal Chemistry, Jan. 1, 1996, pp. 123-132, vol. 31, No. 2, Editions Scientifique Elsevier, Paris, France.
Aubert Jerome
Dumais Laurence
Lamy Laurent
Portal Thibaud
Bianchi Kristin
Buchanan Ingersoll & Rooney P.C.
Galderma Research & Development
Saeed Kamal
LandOfFree
N-phenylacetamide inhibitors of the enzyme SOAT-1 and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-phenylacetamide inhibitors of the enzyme SOAT-1 and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-phenylacetamide inhibitors of the enzyme SOAT-1 and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4283511